Disorders of body water homeostasis

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 17, Issue 4, 2003, Pages 471-503

  Verbalis, Joseph G ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body water; Electrolytes; Vasopressin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AGENTS AFFECTING METABOLISM; ALDOSTERONE; ARGIPRESSIN; CARBAMAZEPINE; CHLORPROPAMIDE; CLOFIBRATE; CLOZAPINE; CYCLOPHOSPHAMIDE; DEMECLOCYCLINE; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; LITHIUM; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OPIATE; OXYTOCIN; PHENOTHIAZINE DERIVATIVE; POTASSIUM; PROSTAGLANDIN INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SULFONYLUREA CHLORPROPAMIDE; TETRACYCLINE DERIVATIVE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOPRESSIN; VINCRISTINE; ELECTROLYTE; SULFONYLUREA;

ADD ON THERAPY; BODY COMPOSITION; BODY FLUID; BODY FLUID COMPARTMENT; BRAIN DISEASE; BRAIN EDEMA; CLINICAL FEATURE; CORRELATION ANALYSIS; DIABETES INSIPIDUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG HALF LIFE; DRUG POTENTIATION; DRUG RESPONSE; DRUG TOXICITY; ELECTROLYTE METABOLISM; EXTRACELLULAR FLUID; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HYPERNATREMIA; HYPEROSMOLARITY; HYPONATREMIA; HYPOOSMOLALITY; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY FUNCTION; METABOLIC DISORDER; MORBIDITY; MORTALITY; NEPHROGENIC DIABETES INSIPIDUS; NEUROLOGIC DISEASE; OSMOLALITY; OSMORECEPTOR; OSMOTIC POTENTIAL; PATHOGENESIS; PATHOPHYSIOLOGY; POLYDIPSIA; POLYURIA; REGULATORY MECHANISM; REVIEW; SODIUM APPETITE; SODIUM EXCRETION; SODIUM METABOLISM; SODIUM URINE LEVEL; STIMULUS RESPONSE; SUPPLEMENTATION; THIRST; TREATMENT INDICATION; URINARY EXCRETION; WATER DEPRIVATION; WATER LOADING; WATER METABOLISM; WATER TRANSPORT; BODY WATER; FLUID INTAKE; HYPEROSMOLALITY; SCHWARTZ BARTTER SYNDROME; SOLUTE;

EID: 0345171005     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-690X(03)00049-6     Document Type: Article

References (65)

1. Fanestil DD. Compartmentation of body water. In Narins RG (ed.) Clinical Disorders of Fluid and Electrolyte Metabolism. New York: McGraw-Hill, 1994, pp. 3-20.
2. Rose BD. New approach to disturbances in the plasma sodium concentration. American Journal of Medicine 1986; 81: 1033-1040.
3. Verbalis JG. The syndrome of inappropriate antidiuretic hormone secretion and other hypoosmolar disorders. In Schrier RW (ed.) Diseases of the Kidney and Urinary Tract. Philadelphia: Lippincott Williams and Wilkins, 2001, pp. 2511-2548.
4. Vokes TP, Aycinena PR and Robertson GL. Effect of insulin on osmoregulation of vasopressin. American Journal of Physiology 1987; 252: E538-E548.
5. Verbalis JG. Body water and osmolality. In Jamison RL & Wilkinson R (eds) Nephrology. London: Chapman & Hall Medical, 1997, pp. 89-94.
6. Fitzsimons JT. Physiology and pathophysiology of thirst and sodium appetite. In Seldin DW & Giebisch G (eds) The Kidney, Physiology and Pathophysiology. New York: Raven Press, 1992, pp. 1615-1648.
7. Stricker EM and Verbalis JG. Water intake and body fluids. In Zigmond MJ, et al. (eds) Fundamental Neuroscience. San Diego: Academic Press, 1999, pp 1111-1126.
8. Robertson GL. Thirst and vasopressin function in normal and disordered states of water balance. Journal of Laboratory and Clinical Medicine 1983; 101: 351-371.
9. Thompson CJ, Bland J, Burd J & Baylis PH. The osmotic thresholds for thirst and vasopressin release are similar in healthy man. Clinical Science (London) 1986; 71: 651-656.
10. Phillips PA, Rolls BJ, Ledingham JG et al. Angiotensin II-induced thirst and vasopressin release in man. Clinical Science (London) 1985; 68: 669-674.
11. De Castro J. A microregulatory analysis of spontaneous fluid intake in humans: Evidence that the amount of liquid ingested and its timing is mainly governed by feeding. Physiology and Behavior 1988; 3: 705-714.
12. Robertson GL. Posterior pituitary. In Felig P, et al. (eds) Endocrinology and Metabolism. New York: McGraw-Hill, 1995, pp 385-432.
13. Knepper MA. Molecular physiology of urinary concentrating mechanism: Regulation of aquaporin water channels by vasopressin. American Journal of Physiology 1997; 272: F3-F12.
14. Robertson GL. The regulation of vasopressin function in health and disease. Recent Progress in Hormone Research 1976; 33: 333-385.
15. Robinson AG. Disorders of antidiuretic hormone secretion. Clinical Endocrinology and Metabolism 1985; 14: 55-88.
16. Rowe JW, Shelton RL, Helderman JH et al. Influence of the emetic reflex on vasopressin release in man. Kidney International 1979; 16: 729-735.
17. Robertson GL, Aycinena P and Zerbe RL. Neurogenic disorders of osmoregulation. American Journal of Medicine 1982; 72; 339-353.
18. Verbalis JG. Body sodium and extracellular fluid volume. In Jamison R & Wilkinson R (eds) Nephrology. London: Chapman & Hall Medical, 1997, pp 95-101.
19. Denton D. The Hunger for Salt: An Anthropological, Physiological and Medical Analysis. Berlin: Springer, 1982.
20. Wilkins L and Richter CP. A great craving for salt by a child with cortico-adrenal insufficiency. JAMA 1940; 114: 866-868.
21. Orth DN and Kovacs WJ. The adrenal cortex. In Wilson JD, et al. (eds) Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders, 1998, pp 517-664.
22. Kirchner KA and Stein JH. Sodium metabolism. In Narins RG (ed.) Clinical Disorders of Fluid and Electrolyte Metabolism. New York: McGraw-Hill, 1994, pp 45-80.
23. Reeves WB and Andreoli TE. Tubular sodium transport. In Schrier RW (ed.) Diseases of the Kidney and Urinary Tract. Philadelphia: Lippincott Williams and Wilkins, 2001, pp 135-175.
24. Baylis C and Lemley KV. Glomerular filtration. In Jamison RL & Wilkinson R (eds) Nephrology. London: Chapman & Hall, 1997, pp 25-33.
25. Masilamani S, Kim GH, Mitchell C et al. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. Journal of Clinical Investigation 1999; 104: R19-R23.
26. Schneider EG, Radke KJ, Ulderich DA and Taylor Jr. RE. Effect of osmolality on aldosterone secretion. Endocrinology 1985; 116: 1621-1626.
27. Hall JE, Granger JP, Smith Jr. MJ and Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone 'escape'. Hypertension 1984; 6: 1183-1192.
28. Verbalis JG. Hyponatremia and hypoosmolar disorders. In Greenberg A (ed.) Primer on Kidney Diseases. San Diego: Academic Press, 2001, pp 57-63.
29. Katz MA. Hyperglycemia-induced hyponatremia - Calculation of expected serum sodium depression. New England Journal of Medicine 1973; 289: 843-844.
30. Hillier TA, Abbott RD & Barrett EJ. Hyponatremia: Evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999; 106: 399-403.
31. Phillips PA, Rolls BJ, Ledingham JG et al. Reduced thirst after water deprivation in healthy elderly men. New England Journal of Medicine 1984; 311: 753-759.
32. Fujiwara TM, Morgan K and Bichet DG. Molecular biology of diabetes insipidus. Annual Review of Medicine 1995; 46: 331-343.
33. Knepper MA, Verbalis JG and Nielsen S. Role of aquaporins in water balance disorders. Current Opinion in Nephrology and Hypertension 1997; 6: 367-371.
34. Zerbe RL and Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. New England Journal of Medicine 1981; 1539-1546.
35. Robertson GL. Diabetes insipidus. Endocrinology and Metabolism Clinics of North America 1995; 24: 549-572.
36. Robertson GL. Dipsogenic diabetes insipidus: A newly recognized syndrome caused by a selective defect in the osmoregulation of thirst. Transactions of the American Association of Physician 1987; 100: 241-249.
37. Thrasher TN, Keil LC and Ramsay DJ. Lesions of the organum vasculosum of the lamina terminalis (OVLT) attenuate osmotically-induced drinking and vasopressin secretion in the dog. Endocrinology 1982; 110: 1837-1839.
38. Johnson AK and Buggy J. Periventricular preoptic-hypothalamus is vital for thirst and normal water economy. American Journal of Physiology 1978; 234: R122-R129.
39. Baylis PH, Thompson CJ. Diabetes insipidus and hyperosmolar syndromes. In Becker KL (ed.) Principles and Practice of Endocrinology and Metabolism. Philadelphia: Lippincott Williams and Wilkins, 2001, pp 285-293.
40. Gullans SR and Verbalis JG. Control of brain volume during hyperosmolar and hypoosmolar conditions. Annual Review of Medicine 1993; 44: 289-301.
41. Robinson AG and Verbalis JG. Diabetes insipidus. Current Therapy in Endocrinology and Metabolism 1997; 6: 1-7.
42. Adrogue HJ and Madias NE. Hypernatremia. New England Journal of Medicine 2000; 342: 1493-1499.
43. Robinson AG. DDAVP in the treatment of central diabetes insipidus. New England Journal of Medicine 1976; 294: 507-511.
44. Spital A. Diuretic-induced hyponatremia. American Journal of Nephrology 1999; 19: 447-452.
45. Chung HM, Kluge R, Schrier RW & Anderson RJ. Clinical assessment of extracellular fluid volume in hyponatremia. American Journal of Medicine 1987; 83: 905-908.
46. Bartter FC & Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. American Journal of Medicine 1967; 42: 790-806.
47. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. New England Journal of Medicine 1989; 321: 492-496.
48. Carroll PB, McHenry L & Verbalis JG. Isolated adrenocorticotrophic hormone deficiency presenting as chronic hyponatremia. New York State Journal of Medicine 1990; 90: 210-213.
49. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (I). New England Journal of Medicine 1988; 319: 1065-1072.
50. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). New England Journal of Medicine 1988; 319: 1127-1134.
51. Adrogue HJ & Madias NE. Hyponatremia. New England Journal of Medicine 2000; 342: 1581-1589.
52. Arieff AI, Llach F & Massry SG. Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes. Medicine 1976; 55: 121-129.
53. Verbalis JG & Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Research 1991; 567; 274-282.
54. Vexler ZS, Ayus JC, Roberts TP et al. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. Journal of Clinical Investigation 1994; 93: 256-264.
55. Ayus JC, Wheeler JM & Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Annals of Internal Medicine 1992; 117: 891-897.
56. Arieff AI, Ayus JC & Fraser CL. Hyponatremia and death or permanent brain damage in healthy children. British Medical Journal 1992; 304: 1218-1222.
57. Fraser CL & Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. American Journal of Medicine 1997; 102: 67-77.
58. Sterns RH, Riggs JE & Schochet Jr. SS. Osmotic demyelination syndrome following correction of hyponatremia. New England Journal of Medicine 1986; 314: 1535-1542.
59. Verbalis JG. Adaptation to acute and chronic hyponatremia: Implications for symptomatology, diagnosis, and therapy. Seminars in Nephrology 1998; 18: 3-19.
60. Sterns RH, Cappuccio JD, Silver SM & Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: A multicenter perspective. Journal of the American Society of Nephrology 1994; 4: 1522-1530.
61. Michelis MF, Fusco RD, Bragdon RW & Davis BB. Reset of osmoreceptors in association with normovolemic hyponatremia. American Journal of the Medical Sciences 1974; 267: 267-273.
62. Forrest Jr. JN, Cox M, Hong C et al. Superiority of democlocycline over lithium in the treament of chronic syndrome of inappropriate secretion of antidiuretic hormone. New England Journal of Medicine 1978; 298: 173-177.
63. Saito T, Ishikawa S, Abe K et al. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Journal of Clinical Endocrinology and Metabolism 1997; 82: 1054-1057.
64. Serradali-Le Gal C, Lacour C, Valette G et al. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. Journal of Clinical Investigation 1996; 98: 2729-2738.
65. Tahara A, Tomura Y, Wada KI et al. Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo. Journal of Pharmacology and Experimental Therapy 1997; 282: 301-308.